INTRODUCTION {#mrm26260-sec-0006}
============

The acid‐base balance within the normal functioning heart is tightly regulated [1](#mrm26260-bib-0001){ref-type="ref"}. Changes in intracellular pH can lead to acute contractile depression, alterations in Ca^2+^ signaling, and electrical arrhythmias [2](#mrm26260-bib-0002){ref-type="ref"}. For example, myocardial ischemia and poor coronary perfusion result in increased anaerobic metabolism and production of lactic acid. The ischemic heart benefits from this initial reduction in cardiac contraction, by preserving adenosine triphosphate (ATP) levels for ion channel homeostasis. Sustained ischemia, however, is maladaptive, as inhibition in Na^+^/K^+^‐ATPase activity and Na^+^/Ca^2+^ exchange lead to calcium overload within the heart.

Few methods exist to noninvasively characterize the intracellular pH (pH~i~) within the body [3](#mrm26260-bib-0003){ref-type="ref"}. ^31^P magnetic resonance spectroscopy (MRS) has long been a gold standard for pH~i~ measurement within the isolated perfused heart [4](#mrm26260-bib-0004){ref-type="ref"}, [5](#mrm26260-bib-0005){ref-type="ref"}. This measurement is based on the pH‐dependent chemical shift of the inorganic phosphate (P~i~) resonance, but is practically limited to ex vivo studies due to 2,3‐diphosphoglycerate (2,3‐DPG) found in ventricular blood, which contaminates the myocardial P~i~ signal [6](#mrm26260-bib-0006){ref-type="ref"}, [7](#mrm26260-bib-0007){ref-type="ref"}. In vivo measurement using ^31^P‐MRS of the intracellular pH across the whole heart is possible by a saturation transfer experiment designed to separate the signal contributions from the intracellular, pH‐sensitive, P~i~, and the extracellular 2,3‐DPG [8](#mrm26260-bib-0008){ref-type="ref"}, but low sensitivity limits this approach to whole‐heart assessment with long scan times. Numerous alternative methods exist for monitoring the pH using magnetic resonance, including spectroscopic probes using ^1^H, ^31^P, and ^19^F MRS [9](#mrm26260-bib-0009){ref-type="ref"}, [10](#mrm26260-bib-0010){ref-type="ref"}, [11](#mrm26260-bib-0011){ref-type="ref"}, [12](#mrm26260-bib-0012){ref-type="ref"}. The sensitivity of these techniques is inherently low, and the resulting chemical shifts are typically small and difficult to resolve at clinical field strengths. The pH‐dependent magnetization transfer between bulk water protons and the endogenous protein amide pool (chemical exchange saturation transfer (CEST)) offers promise, but requires an accurate determination of probe concentration, which is challenging to obtain in vivo [13](#mrm26260-bib-0013){ref-type="ref"}, [14](#mrm26260-bib-0014){ref-type="ref"}.

An attractive option for noninvasive pH~i~ measurement is to exploit the CO~2~/ $\text{HCO}_{3}^{-}$ buffering system of the body. These compounds exist in a pH‐dependent steady state within cardiomyocytes, mediated by a rapid exchange catalyzed by carbonic anhydrase (CA) enzymes. Specifically, ^13^C‐MRS of CO~2~ and $\text{HCO}_{3}^{-}$ concentrations within the heart would enable a ratiometric calculation of pH via the Henderson‐Hasselbalch formula. Unfortunately, this is infeasible using conventional (thermal equilibrium) ^13^C magnetic resonance, because of limited ^13^C natural abundance and the inherently low sensitivity of the MR experiment.

Recent developments in hyperpolarized magnetic resonance using the dissolution dynamic nuclear polarization (DNP) method provide transient signal increases in ^13^C‐labeled substrates relative to their thermal equilibrium polarization in excess of 10000‐fold [15](#mrm26260-bib-0015){ref-type="ref"}. This molecular imaging modality enables imaging of in vivo metabolic changes in real time, within the initial minute of injection into the body. The injection of hyperpolarized \[1‐^13^C\]pyruvate, for example, provides key biochemical information regarding tricarboxylic acid (TCA) cycle flux as well as anaerobic metabolism via observation of \[1‐^13^C\]lactate [16](#mrm26260-bib-0016){ref-type="ref"}, [17](#mrm26260-bib-0017){ref-type="ref"}, [18](#mrm26260-bib-0018){ref-type="ref"}. Injection of hyperpolarized ^13^C‐bicarbonate has previously been used to allow the noninvasive in vivo mapping of extracellular pH by exploiting CA‐mediated exchange within the blood and extracellular space [19](#mrm26260-bib-0019){ref-type="ref"}. This approach has been used to map the acidic extracellular environment within tumors, which is correlated with prognosis and response to treatment. Developments have been made to extensively characterize and optimize extracellular pH measurements using ^13^C‐bicarbonate [20](#mrm26260-bib-0020){ref-type="ref"}, [21](#mrm26260-bib-0021){ref-type="ref"}. Other approaches to generating ^13^C‐bicarbonate have also been investigated, using base‐catalyzed hydrolysis in conjunction with biocompatible ^13^C‐enriched carbonates to reduce toxicity concerns from the presence of Cs^+^ [22](#mrm26260-bib-0022){ref-type="ref"}. An interesting hyperpolarized substrate for extracellular pH measurements has been the application of the Good\'s buffer N‐(2‐acetamido)‐2‐aminoethanesulfonic acid (ACES), which exhibits a pH‐dependent chemical shift [23](#mrm26260-bib-0023){ref-type="ref"}. The production of acetyl‐CoA from hyperpolarized \[1‐^13^C\]pyruvate by pyruvate dehydrogenase (PDH) involves mitochondrial decarboxylation as an initial step before entry into the TCA cycle. This results in the production of intracellular hyperpolarized ^13^CO~2~, which is vented from the mitochondrial matrix into the cytoplasm, where a cytosolic CA isoform catalyzes the rapid exchange with H^13^ $\text{CO}_{3}^{-}$. The ratio of these two signals can be used for determination of intracellular pH [24](#mrm26260-bib-0024){ref-type="ref"}, [25](#mrm26260-bib-0025){ref-type="ref"}. At physiological pH, the low ^13^CO~2~ signal (approximately 10% of myocardial H^13^ $\text{CO}_{3}^{-}$) is often at the limit of detection, which has up until now restricted this technique to whole‐heart assessment [18](#mrm26260-bib-0018){ref-type="ref"}, [25](#mrm26260-bib-0025){ref-type="ref"}. Although nonlocalized methods can be useful in physiological states, which affect the heart on a global level, they are insufficient when studying focal regions of ischemia. To use hyperpolarized ^13^C‐based intracellular pH measurements to identify focal regions of myocardial ischemia, it will be necessary to develop optimized data acquisition methods that increase the measured ^13^CO~2~ signal.

The aim of this study was to investigate the feasibility of performing in vivo pH~i~ mapping in the heart, using hyperpolarized ^13^C MRI. To this aim, we have developed an optimized data acquisition in which spectrally selective radiofrequency (RF) pulses are used to excite the $\text{HCO}_{3}^{-}$ and CO~2~ resonances individually while preserving signal from \[1‐^13^C\]pyruvate. A variable timing scheme is used to exploit CA‐mediated label exchange between $\text{HCO}_{3}^{-}$ and CO~2~, which enables the use of large flip angles for a 3D imaging acquisition. Images at 4.5 × 4.5 × 5 mm^3^ resolution are obtained in the in vivo rodent heart. The technique is evaluated in healthy rodents scanned at baseline and during high cardiac workload induced by dobutamine infusion. The new method is anticipated to enable new cardiovascular imaging examinations in which the severity of stress‐inducible ischemia can be evaluated.

METHODS {#mrm26260-sec-0007}
=======

All experiments were performed on an Agilent 7 Tesla (T) MRI system (Agilent, Santa Clara, California). All animal investigations conformed to Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act (HMSO) of 1986, to institutional guidelines, and were approved by the University of Oxford Animal Ethics Review Committee.

Animal Handling {#mrm26260-sec-0008}
---------------

Male Wistar rats (n = 5, weight = 500 ± 20 g) were scanned in this study. Two animals were used in initial pilot scans to determine the feasibility of the spectrally selective excitation scheme used for subsequent imaging studies. A further three animals were then scanned in two separate scan sessions consisting of rest and stress conditions to demonstrate the feasibility of the newly developed 3D imaging sequence, described subsequently. Anesthesia was induced at 2.5--3% isoflurane in oxygen and nitrous oxide (4:1, total of 2 L/min). Anesthesia was maintained by means of 2% isoflurane delivered to, and scavenged from, a nose cone during the experiment. A tail vein catheter was placed for intravenous injection of hyperpolarized \[1‐^13^C\]pyruvate. When required, a separate tail vein catheter was placed in the contralateral tail vein for delivery of dobutamine during the high cardiac workload experiments, described subsequently. Animals were then placed in a home‐built animal handling system [26](#mrm26260-bib-0026){ref-type="ref"}. Body temperature was maintained using air heating, and a two‐lead electrocardiogram (ECG) for cardiac gating was obtained using leads placed subcutaneously into the upper forelimbs.

Modulation of Cardiac Workload {#mrm26260-sec-0009}
------------------------------

Scans were performed in a group of three subjects (n = 3, weight 530 ± 20 g) in separate experiments under either rest or stress conditions. Cardiac workload was increased by continuous dobutamine infusion (concentration 1 mg/mL, dose 100 μg/kg/min, Hameln Pharma Plus GmbH, Germany) into the tail vein using a small animal infusion pump (Harvard Apparatus, Holliston, Massachusetts). The volume of the injection line was filled with dobutamine, and hyperpolarized \[1‐^13^C\] pyruvate was administered 15 min after the start of infusion through a separate tail vein catheter. Dobutamine infusion was maintained throughout the ^13^C scan. The heart rate immediately prior to hyperpolarized \[1‐^13^C\]pyruvate injection was 380 ± 20 bpm at rest and 450 ± 10 bpm during stress (*P* \< 0.05, paired t‐test).

Hyperpolarization {#mrm26260-sec-0010}
-----------------

\[1‐^13^C\]pyruvic acid (14 M neat with 15 mM OX063 trityl radical and 0.8 mM Gd‐DOTA) was hyperpolarized in a prototype DNP hyperpolarizer at 93.979 GHz and 100 mW for 60 min [15](#mrm26260-bib-0015){ref-type="ref"}. Dissolution was performed at a pressure of 10 bar and a temperature of ∼170 °C in 6 mL of NaOH solution resulting in a pH ∼7 solution of 80 mM \[1‐^13^C\]pyruvate. A total of 2 mL of hyperpolarized \[1‐^13^C\]pyruvate was injected over 20 s via the tail vein.

MRI Acquisitions {#mrm26260-sec-0011}
----------------

^1^H images were acquired using a 72‐mm inner diameter dual‐tuned birdcage transmit/receive ^1^H/^13^C coil (Rapid Biomedical GmbH, Rimpar, Germany). ^13^C images were acquired using the same volumetric coil for RF transmission, and a two‐channel surface receive array (two 2 × 4 cm^2^ elements oriented in the left‐right direction) for signal reception (Rapid Biomedical GmbH, Rimpar, Germany). The surface coil was positioned on the anterior chest wall, and a thermally polarized 5 M ^13^C urea phantom was used to calibrate the ^13^C transmitter power before the ^13^C scans. A 180° pulse was calibrated by finding the power required to null the signal from this phantom. The $B_{1}^{+}$ for the volume ^13^C transmit coil was measured in previous phantom experiments using a double‐angle gradient echo (GRE) acquisition, and was found to have a coefficient of variation (SD/mean) of 4% over a cylindrical volume encompassing the sensitive region of the coil (diameter 40 mm, height 40 mm). A volume covering a 40‐mm slab including the heart was used for shimming using a 3D gradient‐echo automated shim routine [27](#mrm26260-bib-0027){ref-type="ref"}. An axial stack of ECG‐gated, segmented GRE images covering the 40‐mm slab were used for anatomical reference (16 slices, pulse repetition time (TR) 3.3 ms, echo time (TE) 1.3 ms, 128 × 128 matrix, field of view (FOV) 60 × 60 mm^2^, slice thickness 2.5 mm, 8 averages, 64 segments, bandwidth (BW) 1150 Hz/pixel). ECG‐gated ^1^H cine imaging was used to assess cardiac function in a single midventricular short‐axis slice in the increased cardiac workload experiments (TR 4.6 ms, TE 1.6 ms, 128 × 128 matrix, FOV 60 × 60 mm^2^, slice thickness 1.6 mm, 8 averages, BW 1150 Hz/pixel). Function was assessed both at baseline and 5 min following the beginning of dobutamine infusion.

RF Pulse Design {#mrm26260-sec-0012}
---------------

Using the Shinnar Le‐Roux (SLR) algorithm [28](#mrm26260-bib-0028){ref-type="ref"}, minimum phase, spectrally selective, and spatially nonselective RF pulses were designed to excite either $\text{HCO}_{3}^{-}$ (160 ppm, 20° flip angle) or CO~2~ (124.5 ppm, 70° flip angle) individually, while leaving \[1‐^13^C\]pyruvate (170 ppm) unexcited (parameters: duration 10 ms, time bandwidth product 6, 3.0‐ppm passband (95%), 10^−5^ stopband (6.5 ppm from the center of the passband)). An open‐source RF pulse design toolbox was used to generate these pulses (<http://rsl.stanford.edu/research/software.html>). The RF pulse for 20° $\text{HCO}_{3}^{-}$ excitation is shown in Figure [1](#mrm26260-fig-0001){ref-type="fig"}a. The corresponding spectral profiles, shown in Figure [1](#mrm26260-fig-0001){ref-type="fig"}b, are acquired by sweeping the transmitter frequency across a 2000 kHz (26 ppm) range, and obtaining individual free induction decays (FIDs) from a phantom containing thermally polarized, 5M ^13^C enriched urea (phantom T~1~ 75 ms; scan parameters: TR 400 ms, 8 kHz bandwidth, 2048 points, 256 ms readout, nominal flip angle 20° on resonance, 81 frequency steps). The experimental profiles show good agreement with Bloch simulation, revealing a suppression level of at least 10^−3^, with the remaining discrepancies likely caused by RF amplifier nonlinearities [29](#mrm26260-bib-0029){ref-type="ref"}.

![(a) Spectrally selective, minimum phase radiofrequency pulse designed to excite $\text{HCO}_{3}^{-}$ (160 ppm) while leaving \[1‐^13^C\]pyruvate (170 ppm) unexcited. (b) Experimentally measured spectral profiles using thermally polarized, 5 M ^13^C urea show good agreement with Bloch simulation (top: real and imaginary response; bottom: magnitude response) with residual errors likely due to RF amplifier nonlinearities.](MRM-77-1810-g001){#mrm26260-fig-0001}

An ECG‐gated pulse‐and‐acquire sequence was used to demonstrate the signal‐to‐noise ratio (SNR) gain from the large flip angle excitation and to determine the optimal timing window for subsequent imaging experiments of myocardial $\text{HCO}_{3}^{-}$ and CO~2~ (parameters: TR 1 s, 13 kHz bandwidth, 8192 points, 630 ms readout). The sequence alternated between excitation of all metabolites (hard pulse, 50 μs duration, 10°), of $\text{HCO}_{3}^{-}$ only (10 ms duration, 20°), or of CO~2~ only (10 ms duration, 70°).

Figure [2](#mrm26260-fig-0002){ref-type="fig"}a shows the sum of 1 min of data acquisition obtained following injection of hyperpolarized \[1‐^13^C\]pyruvate using the different excitation pulses. These spectra show signals from a nonselective 10° hard pulse excitation in blue, as well as signals from spectrally selective excitation (20° centered on $\text{HCO}_{3}^{-}$ in red, 70° centered on CO~2~ in green). The acquired spectra are localized to the heart as a result of coil placement. Figure [2](#mrm26260-fig-0002){ref-type="fig"}b shows 1 min of dynamic ECG‐gated spectra using the alternating excitation scheme. It is clear that improved signal‐to‐noise ratios are obtained by using the selective excitation pulse. The higher flip angle selective pulses result in an SNR gain of 1.7‐fold for $\text{HCO}_{3}^{-}$ and 3.1‐fold for CO~2~. Furthermore, despite the large flip angles (70°) delivered to the CO~2~ resonance, rapid exchange with the $\text{HCO}_{3}^{-}$ pool and new production from unaffected pyruvate regenerate this peak for subsequent measurements.

![(a) Summed spectra obtained following injection of \[1‐^13^C\]pyruvate are shown using different excitation schemes (blue: nonselective; red: $\text{HCO}_{3}^{-}$ only; green: CO~2~ only). (b) Time courses over 1 min of data acquisition, showing the SNR gain from selective, large flip angle excitation.](MRM-77-1810-g002){#mrm26260-fig-0002}

3D Imaging Pulse Sequence {#mrm26260-sec-0013}
-------------------------

Figure [3](#mrm26260-fig-0003){ref-type="fig"}a shows the 3D ECG‐gated pulse sequence used to obtain axial images of $\text{HCO}_{3}^{-}$ and CO~2~ in the heart. A stack‐of‐spirals trajectory was used for spatial encoding (FOV 60 × 60 × 40 mm^3^, readout duration 6 ms, in‐plane resolution 4.5 × 4.5 × 5.0 mm^2^, 8 phase encodes, TE 4.3 ms). The eight phase encodes were acquired in a linear order across k‐space. Sequential CO~2~ and $\text{HCO}_{3}^{-}$ volumes were acquired by switching the excitation pulse used in each block. The TR was varied between the two resonances to allow for regeneration of CO~2~ from the larger $\text{HCO}_{3}^{-}$ resonance (TR 500 ms for CO~2~, 150 ms for $\text{HCO}_{3}^{-}$). The time required to acquire the two metabolic volumes was 6 s.

![(a) 3D sequence used to image $\text{HCO}_{3}^{-}$ and CO~2~ in the heart. Eight phase encodes are required per volume; the TR is varied to allow magnetization transfer between CO~2~ and $\text{HCO}_{3}^{-}$ pools following large flip angle excitation of CO~2~. Each triangular arrowhead indicates the beginning of a cardiac RR interval. (b) Nonlocalized ECG‐gated spectra show the feasibility of this approach.](MRM-77-1810-g003){#mrm26260-fig-0003}

Figure [3](#mrm26260-fig-0003){ref-type="fig"}b shows the feasibility of using this acquisition scheme for 3D imaging. Whole‐heart ECG‐gated spectra were acquired with the readout gradients turned off with the repetition time set to 500 ms for both resonances. The scan was started 10 s after the start of injection. This scan timing was determined from the time course in Figure [2](#mrm26260-fig-0002){ref-type="fig"}b and was chosen to capture both maximum $\text{HCO}_{3}^{-}$ and CO~2~ signal. High SNR spectra can be obtained for at least 40 s after the start of the scan.

Image Reconstruction and Data Analysis {#mrm26260-sec-0014}
--------------------------------------

The spiral trajectory was predicted using a premeasured gradient impulse response function [30](#mrm26260-bib-0030){ref-type="ref"}. Following Fourier transformation (FFT) along the slab direction, non‐Cartesian k‐space samples were gridded using the nonuniform fast Fourier transform [31](#mrm26260-bib-0031){ref-type="ref"}, [32](#mrm26260-bib-0032){ref-type="ref"}. Images were corrected for variable flip angle by dividing each image by $\sin\theta$. Linear nearest‐neighbor interpolation using the image magnitude was used to fill in missing $\text{HCO}_{3}^{-}$ and CO~2~ images in the corresponding time series. pH~i~ was estimated using the Henderson‐Hasselbalch equation ( $\text{pH} = {pK}_{a} + ~{\mathit{\log}_{10}{{HCO}_{3}^{‐}/{CO}_{2}}}$) with pK~a~ = 6.15. pH~i~ maps were masked by including only voxels that reached four standard deviations above the mean magnitude $\text{HCO}_{3}^{-}$ noise signal in the final analysis.

A paired, two‐tailed Student\'s t‐test was used to compare pH values between rest and dobutamine stress conditions. Statistical significance was considered at the *P* \< 0.05 level.

RESULTS {#mrm26260-sec-0015}
=======

Figure [4](#mrm26260-fig-0004){ref-type="fig"} shows dynamic imaging of $\text{HCO}_{3}^{-}$ and CO~2~ using the 3D pH~i~ mapping pulse sequence in a midventricular slice. This set of images directly demonstrates the localization of $\text{HCO}_{3}^{-}$ and CO~2~ signals to the myocardium, with no detectable signal within the blood pool. The images with dashed borders were linearly interpolated from neighboring time points. The initial missing $\text{HCO}_{3}^{-}$ time point was linearly extrapolated from the first two frames of the $\text{HCO}_{3}^{-}$ time series. The acquisition time for the central k~z~ spiral readout was used as the time point for each image, and this varied between frames resulting from slight variations in heart rate over the course of the scan.

![Dynamic imaging of $\text{HCO}_{3}^{-}$ and CO~2~ in a midventricular slice following injection of HP \[1‐^13^C\]pyruvate. The images marked with dashed borders are interpolated from adjacent frames. Images are cropped to a 30 x 30 mm^2^ FOV.](MRM-77-1810-g004){#mrm26260-fig-0004}

Figure [5](#mrm26260-fig-0005){ref-type="fig"} shows volumetric images of $\text{HCO}_{3}^{-}$ and CO~2~ in the rodent heart, summed over the first 20 s of data acquisition at both rest and during high cardiac workload. The surface coil placement on the chest wall next to the heart and high cardiac PDH flux localize $\text{HCO}_{3}^{-}$ and CO~2~ signals to the heart, demonstrating that any aliasing of $\text{HCO}_{3}^{-}$ or CO~2~ from outside of the FOV is negligible. Spatial pH~i~ maps using the ratio between $\text{HCO}_{3}^{-}$ and CO~2~ images 20 s following the start of injection show pH~i~ = 7.2 ± 0.2 at rest (mean ± SD) across the heart in this subject. In a separate experiment, injection of hyperpolarized \[1‐^13^C\]pyruvate during a continuous dobutamine infusion revealed a decrease in pH~i~ to 6.8 ± 0.2 in this subject.

![Volumetric images of $\text{HCO}_{3}^{-}$ and CO~2~ using the 3D sequence. The first 20 s of data are summed. CO~2~ intensity is increased 10‐fold. Spatial pH~i~ maps reveal pH~i~ = 7.19 ± 0.21 at rest and 6.84 ± 0.17 at stress in this subject. Images are cropped to a 30 x 30 x 30 mm^3^ FOV.](MRM-77-1810-g005){#mrm26260-fig-0005}

Figure [6](#mrm26260-fig-0006){ref-type="fig"} shows midventricular pH~i~ maps (20 s after the start of injection) in multiple subjects. The $\text{HCO}_{3}^{-}$ and CO~2~ images are localized to the myocardial tissue, as shown by the anatomical segmented GRE images. The pH maps demonstrate a uniform myocardial pH~i~ of 7.15 ± 0.04 (mean ± SD over the group, n = 3) across the whole heart, at rest, consistent with global pH~i~ measurements in rats and pigs [18](#mrm26260-bib-0018){ref-type="ref"}, [25](#mrm26260-bib-0025){ref-type="ref"}. Following 15 min of high cardiac workload, pH~i~ decreased to 6.90 ± 0.06 (*P* \< 0.05, paired t‐test). Figure [6](#mrm26260-fig-0006){ref-type="fig"}b shows the statistical comparison between mean myocardial pH~i~ at rest and during dobutamine stress.

![(a) Intracellular pH measurements obtained using the ratio between $\text{HCO}_{3}^{-}$ and CO~2~ from a mid‐ventricular slice. Images are cropped to a 30x30 mm^2^ FOV. The scale bar indicates 1 cm. The ^13^C images are taken from a single time point, 20 seconds after the start of injection. (b) Increased cardiac workload results in decreased apparent pH~i~ in the healthy heart.](MRM-77-1810-g006){#mrm26260-fig-0006}

DISCUSSION {#mrm26260-sec-0016}
==========

Significance {#mrm26260-sec-0017}
------------

The proper functioning of cells relies on tight control of intracellular pH. Despite the vital importance of this physiological parameter, rapid noninvasive mapping of intracellular pH within the in vivo heart is impossible with existing techniques. Here, we build upon the previous use of hyperpolarized substrates [18](#mrm26260-bib-0018){ref-type="ref"}, [19](#mrm26260-bib-0019){ref-type="ref"}, [25](#mrm26260-bib-0025){ref-type="ref"} and describe a new method that exploits the body\'s natural $\text{HCO}_{3}^{-}$/CO~2~ buffering system to obtain a spatial three‐dimensional map of the myocardial intracellular pH. The sensitivity of the method is demonstrated by detection of a decrease in pH~i~ following 15 min of high cardiac workload.

It is anticipated that this development will enable new experimental paradigms in which acute, focal alterations in pH can be detected in vivo. Disruption to the acid‐base balance within cells affects enzyme activity, ion channel behavior, Ca^2+^ handling, and contractile function. Under certain conditions, a decline in cardiac pH~i~ can trigger electrical arrhythmia [2](#mrm26260-bib-0002){ref-type="ref"}, leading to sudden cardiac death. The ability to create a spatial map of pH~i~ could allow assessment of stress‐inducible ischemia and potential ventricular arrythmogenic substrates within the ischemic heart.

Technical Discussion {#mrm26260-sec-0018}
--------------------

The correct use of the Henderson‐Hasselbalch equation for intracellular pH measurement requires that two necessary conditions are satisfied [25](#mrm26260-bib-0025){ref-type="ref"}. The first of these conditions is that the hyperpolarized acid‐base pair must be in rapid exchange. This condition is satisfied at physiological pH values in which CA enzyme activity is high. If CA activity is low, as may be the case at reduced pH found in ischemia, then ^13^CO~2~ and H^13^ $\text{CO}_{3}^{-}$ may not equilibrate on the time scale of the hyperpolarized ^13^C experiment. The effect of this incomplete equilibration would result in an artefactual low pH~i~ measurement. Previous work has shown agreement between ^13^C and ^31^P‐MRS measurements in isolated, perfused hearts subjected to ischemia and subsequent reperfusion [25](#mrm26260-bib-0025){ref-type="ref"}, which indicates that CA activity is sufficiently high even following an ischemic event.

The second condition is that the acid‐base pair are detected from the same cellular compartment. In rodents, mitochondrial CA activity is low, and mitochondrial CO~2~ is vented into a cytoplasmic domain with elevated CA activity [24](#mrm26260-bib-0024){ref-type="ref"}. CO~2~ efflux from the myocardium into the extracellular space is likely low on the experimental timescale, as the ratio between $\text{HCO}_{3}^{-}$ and CO~2~ reaches a plateau within 5 s in vivo [25](#mrm26260-bib-0025){ref-type="ref"}. The images indicate that $\text{HCO}_{3}^{-}$ and CO~2~ are confined to the myocardium, which is dominated by the intracellular space. The close agreement of the hyperpolarized ^13^C pH measurement with the ^31^P measurement in the perfused heart indicates minimal contamination with the extracellular space [25](#mrm26260-bib-0025){ref-type="ref"}. CO~2~ venting from the myocardium into the blood is likely low, as no $\text{HCO}_{3}^{-}$ or CO~2~ signals were visualized within the blood pool here. The absence of any $\text{HCO}_{3}^{-}$ and CO~2~ signal within the blood pool is consistent with dilution into a much larger volume, the fact that mature erythrocytes are anucleate and lack mitochondria, and association of ^13^CO~2~ with hemoglobin, which would shorten the T~1~ and rapidly remove the hyperpolarized signal. It is interesting to contrast the rapid steady state reached in rodents to measurements made in pigs, in which the measured pH~i~ appears to rise over a 20 s period, suggesting a difference between species in the rate at which ^13^CO~2~ leaves the cytosolic compartment during the duration of the experiment [18](#mrm26260-bib-0018){ref-type="ref"}.

Dobutamine, a β~1~‐adrenergic agonist, is a positive inotrope used clinically to increase cardiac workload as a pharmacologic stress testing agent [33](#mrm26260-bib-0033){ref-type="ref"}. Continuous dobutamine infusion and increased cardiac workload result in increased PDH and TCA cycle flux, as well as increased glycolysis, leading to the production of excess intracellular lactic acid [34](#mrm26260-bib-0034){ref-type="ref"}, [35](#mrm26260-bib-0035){ref-type="ref"}. The delivery of hyperpolarized pyruvate directly probes an increase in the intracellular lactate pool size, as demonstrated by previous studies using hyperpolarized pyruvate in rats [36](#mrm26260-bib-0036){ref-type="ref"}, [37](#mrm26260-bib-0037){ref-type="ref"} and pigs [38](#mrm26260-bib-0038){ref-type="ref"}, [39](#mrm26260-bib-0039){ref-type="ref"}. Here, we demonstrate that the increase in glycolysis results in an appreciable intracellular pH change during normoxia, which can also be probed using hyperpolarized \[1‐^13^C\]pyruvate, despite the high intracellular buffering capacity and normal perfusion of the myocardium. Similarly, increased cardiac workload reduces intracellular pH in isolated cardiomyocytes during high‐frequency electrical stimulation [40](#mrm26260-bib-0040){ref-type="ref"}, as well as following β‐adrenergic stimulation using isoprenaline [41](#mrm26260-bib-0041){ref-type="ref"}.

The optimized acquisition in this study uses spectrally selective imaging of the $\text{HCO}_{3}^{-}$ and CO~2~ resonances to preserve the limited reservoir of hyperpolarized \[1‐^13^C\]pyruvate magnetization [18](#mrm26260-bib-0018){ref-type="ref"}, [42](#mrm26260-bib-0042){ref-type="ref"}, [43](#mrm26260-bib-0043){ref-type="ref"}, [44](#mrm26260-bib-0044){ref-type="ref"}, [45](#mrm26260-bib-0045){ref-type="ref"}, [46](#mrm26260-bib-0046){ref-type="ref"}, [47](#mrm26260-bib-0047){ref-type="ref"}. As the method is based on the ratio between $\text{HCO}_{3}^{-}$ and CO~2~ signals, the measured pH is independent of the concentration of pyruvate or its downstream metabolites. The main requirement is that the PDH flux is high enough to enable the detection of CO~2~ and $\text{HCO}_{3}^{-}$ within the cell. One limitation of this approach is that the arrival of pyruvate into the heart is not monitored. Although pyruvate concentration is not required for pH determination, imaging the arrival of hyperpolarized pyruvate at the heart would allow a simultaneous measurement of cardiac PDH flux, which would be useful to assess tissue viability [18](#mrm26260-bib-0018){ref-type="ref"}. Pyruvate images could also be used to determine the optimal time to acquire $\text{HCO}_{3}^{-}$ and CO~2~ images, which would be useful in a heterogeneous subject group in which the arterial input function is expected to be variable. Alternatively, co‐polarization of metabolically inert ^13^C urea alongside \[1‐^13^C\]pyruvate could be used to obtain the arrival time without disturbing the hyperpolarized pyruvate magnetization [48](#mrm26260-bib-0048){ref-type="ref"}, [49](#mrm26260-bib-0049){ref-type="ref"}.

The limiting factor for accurate pH~i~ determination is the relatively low SNR of the CO~2~ signal specifically, which is 10% of the $\text{HCO}_{3}^{-}$ signal at physiological pH levels. This is consistent with an error propagation analysis of the Henderson‐Hasselbalch equation, which leads to $\sigma_{pH}^{2} = \left( {1/{SNR}_{bic}} \right)^{2} + \left( {1/{SNR}_{CO2}} \right)^{2}$, where $\sigma_{X}$ denotes the standard deviation of X, and ${SNR}_{X} = {X/\sigma_{X}}$ denotes the signal‐to‐noise ratio. The SNR of the CO~2~ is typically ∼5 in the in vivo experiments shown here, which is consistent with the single subject standard deviation reported in Figure [5](#mrm26260-fig-0005){ref-type="fig"}. A 70° flip angle was used to excite CO~2~; this angle was chosen to improve SNR while avoiding excitation by flip angles above 90° due to $B_{1}^{+}$ inhomogeneity, which would decrease the CO~2~ signal. This is a reasonable trade‐off, as the transverse magnetization created by 70° excitations is 94% that of a 90° excitation.

The CO~2~ SNR may further be improved by shortening the duration of the CO~2~ excitation. Specifically, the 10 ms pulse used for excitation of $\text{HCO}_{3}^{-}$ (170 ppm) was designed to avoid excitation of \[1‐^13^C\]pyruvate (160 ppm). CO~2~, which is positioned at 124.5 ppm, is three times further away in chemical shift, and a shortened pulse (∼3.5 ms) would reduce the effective echo time and reduce $T_{2}^{*}$‐related dephasing across the volume. Although this could potentially improve SNR, the difference in echo time would need to be compensated by $T_{2}^{*}$ mapping within the heart. This could be done using multiecho ^1^H images, and converting the $T_{2}^{*}$ values to ^13^C via multiplication by γ~1H~/γ~13C~ ≈ 4.

Currently, the validation of noninvasive methods for intracellular pH mapping within the myocardium is challenging. The gold standard for noninvasive intracellular pH measurement, ^31^P‐MRS, suffers from contamination of the pH‐sensitive P~i~ resonance with 2,3‐diphosphoglycerate (2,3‐DPG) found in the ventricular blood. It is possible to perform a saturation transfer experiment to remove the contribution from 2,3‐DPG, but this method remains limited to a whole‐heart measurement with long scan time due to limited SNR [8](#mrm26260-bib-0008){ref-type="ref"}. The ^13^C and ^31^P‐based measurements agree in isolated, perfused rat hearts in which blood is not present [25](#mrm26260-bib-0025){ref-type="ref"}. Invasive measurements using either blood replacement [6](#mrm26260-bib-0006){ref-type="ref"} or open‐chest techniques [7](#mrm26260-bib-0007){ref-type="ref"} may be of value for correlation with the noninvasive hyperpolarized ^13^C measurements described here.

Clinical Translation {#mrm26260-sec-0019}
--------------------

The use of hyperpolarized ^13^C substrates to study human heart disease is rapidly approaching the clinic. The first application of hyperpolarized magnetic resonance in humans at the University of California, San Francisco, demonstrated the potential of the technique to stage prostate cancer and assess the response to treatment [50](#mrm26260-bib-0050){ref-type="ref"}. New hyperpolarizer designs that produce sterile, clinical‐grade tracers for human use are now available [51](#mrm26260-bib-0051){ref-type="ref"}. Hyperpolarized pyruvate is approved for use in physiological studies that will be centered on assessing metabolic conversion within the heart into lactate, alanine, and bicarbonate as sensitive markers of cellular viability and metabolic state. Therefore, intracellular pH mapping, using the metabolic products of hyperpolarized \[1‐^13^C\]pyruvate, has a direct path for clinical translation.

CONCLUSIONS {#mrm26260-sec-0020}
===========

An optimized sequence for mapping intracellular pH within the rodent heart in under a minute is proposed. Following an injection of hyperpolarized \[1‐^13^C\]pyruvate, mitochondrial decarboxylation results in cytosolic CO~2~ and $\text{HCO}_{3}^{-}$. Spectrally selective excitation is combined with a rapid 3D imaging readout, and the rapid regeneration of CO~2~ due to carbonic anhydrase‐mediated exchange is used to obtain whole‐heart intracellular pH maps in vivo. The intracellular pH was measured to be 7.15 ± 0.04 at baseline, and decreased to 6.90 ± 0.06 following 15 min of continuous β‐adrenergic stimulation. The new method is anticipated to enable assessment of stress‐inducible ischemia and potential ventricular arrhythmogenic substrates within the ischemic heart.
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